Inhaler types in Hospital

1. ©Respiratory Quality Improvement Group, June 2016
Inhaler Devices Identification Chart
Short Acting Beta2 Agonists (SABA)
Short Acting Muscarinic
Antagonists (SAMA)
Combination SABA +
SAMA
RELIEVERS
SALBUTAMOL TERBUTALINE IPRATROPIUM SALBUTAMOL + IPRATROPIUM
100mcg 100mcg 100mcg 100mcg 250mcg 20mcg 100/20
Respigen SalAir Ventolin Salamol Bricanyl Turbuhaler Atrovent Duolin HFA
Inhaled Corticosteroids (ICS)
PREVENTERS
FLUTICASONE propionate
Aerosol inhaler and Accuhaler
BUDESONIDE
BECLOMETHASONE
dipropionate
BECLOMETHASONE
dipropionate (ultra fine particle)
50mcg 125mcg 250mcg 50mcg 125mcg 250mcg 50mcg 100mcg 250mcg 100mcg 200mcg 400mcg 50mcg 100mcg 250mcg 50mcg 100mcg
Floair Flixotide Flixotide Accuhaler Pulmicort Turbuhaler Beclazone Qvar
Combination Inhaled Corticosteroids (ICS) + Long Acting Beta2 Agonists (LABA)
FLUTICASONE propionate + SALMETEROL
Aerosol inhaler and Accuhaler
FLUTICASONE furoate
+ VILANTEROL
BUDESONIDE + FORMOTEROL
Turbuhaler and Aerosol inhaler
50/25 125/25 250/25 50/25 125/25 250/25 100/50 250/50 100/25 200/25 100/6 200/6 400/12 100/6 200/6
RexAir Seretide Seretide Accuhaler Breo Ellipta Symbicort Turbuhaler Vannair
Subsidised Inhalers for Asthma or COPD New Zealand March 2016
SABA – Short-Acting Beta2 Agonists
SALBUTAMOL Aerosol inhaler
100mcg/puff
TERBUTALINE powder for inhalation
250mcg/dose
Respigen SalAir Salamol Ventolin Bricanyl Turbuhaler
SAMA – Short-Acting Muscarinic Antagonists Combination SABA
IPRATROPIUM Aerosol inhaler
20mcg/puff
IPRATROPIUM Nebuliser solution
250 mcg/mL
500mcg/2mL
SALBUTAMOL WITH IPRATROPIUM
Aerosol inhaler
salbutamol 100 mcg +
ipratropium 20 mcg /puff
SA
Atrovent Univent Duolin
Mast Cell Stabilisers
SODIUM CROMOGLYCATE Powder for inhalation SODIUM CROMOGLYCATE Aerosol inhaler NEDOC
(see note 3)
Subsidised Inhalers for Asthma or COPD New Zealand March 2016
SABA – Short-Acting Beta2 Agonists
SALBUTAMOL Aerosol inhaler
100mcg/puff
TERBUTALINE powder for inhalation
250mcg/dose
SALBU
spigen SalAir Salamol Ventolin Bricanyl Turbuhaler
SAMA – Short-Acting Muscarinic Antagonists Combination SABA & SAMA
TROPIUM Aerosol inhaler
20mcg/puff
IPRATROPIUM Nebuliser solution
250 mcg/mL
500mcg/2mL
SALBUTAMOL WITH IPRATROPIUM
Aerosol inhaler
salbutamol 100 mcg +
ipratropium 20 mcg /puff
SALBUTAMO
Neb
salbu
ipratropi
Atrovent Univent Duolin
Mast Cell Stabilisers
UM CROMOGLYCATE Powder for inhalation SODIUM CROMOGLYCATE Aerosol inhaler NEDOCROMIL Ae
(see note 3)
e
FLUTICASONE propionate
Aerosol inhalers
50mcg/dose 125mcg/dose 250mcg/dose
FLUTICASONE propionate
powder for inhalation
50mcg/dose 125mcg/dose
250mcg/dose
Floair Flixotide Flixotide Accuhaler
d
e
Fluticasone and beclomethasone dipropionate are NOT dose equivalent
Fluticasone is approximately twice as potent as standard beclomethasone dipropionate
(Beclazone)
A
Combination ONCE
daily ICS & LABA
PIONATE & SALMETEROL
sol inhaler
sone propionate &
almeterol/puff
asone propionate &
almeterol/puff
: 250mcg fluticasone
5mcg salmeterol/puff
FLUTICASONE PROPIONATE &
SALMETEROL
powder for inhalation
100mcg fluticasone propionate &
50mcg salmeterol/dose
250mcg fluticasone propionate &
50mcg salmeterol/dose
FLUTICASONE FUROATE &
VILANTEROL
powder for inhalation
Fluticasone furoate 100mcg &
vilanterol 25 mcg
(Asthma and COPD)
Fluticasone furoate 200mcg &
vilanterol 25 mcg
(Asthma only)
Seretide Seretide Accuhaler Breo Ellipta
esentations are NOT dose equivalent with Accuhaler
25mcg salmeterol - Accuhalers contain 50mcg salmeterol
puffs twice daily; Accuhaler: ONE inhalation twice daily
costeroid is needed, change to the higher strength presentation
Fluticasone furoate
100mcg ONCE daily
is approx. equivalent to
fluticasone propionate
Fully subsidised - Special Authority removed
sthma or COPD New Zealand March 2016
nhaled Corticosteroids
tion
mcg/dose
FLUTICASONE propionate
Aerosol inhalers
50mcg/dose 125mcg/dose 250mcg/dose
FLUTICASONE propionate
powder for inhalation
50mcg/dose 125mcg/dose
250mcg/dose
aler Floair Flixotide Flixotide Accuhaler
imately
tandard
opionate
Fluticasone and beclomethasone dipropionate are NOT dose equivalent
Fluticasone is approximately twice as potent as standard beclomethasone dipropionate
(Beclazone)
& LABA
Combination ONCE
daily ICS & LABA
NE PROPIONATE & SALMETEROL
Aerosol inhaler
g fluticasone propionate &
5mcg salmeterol/puff
cg fluticasone propionate &
5mcg salmeterol/puff
bsidised: 250mcg fluticasone
ate & 25mcg salmeterol/puff
FLUTICASONE PROPIONATE &
SALMETEROL
powder for inhalation
100mcg fluticasone propionate &
50mcg salmeterol/dose
250mcg fluticasone propionate &
50mcg salmeterol/dose
FLUTICASONE FUROATE &
VILANTEROL
powder for inhalation
Fluticasone furoate 100mcg &
vilanterol 25 mcg
(Asthma and COPD)
Fluticasone furoate 200mcg &
vilanterol 25 mcg
(Asthma only)
Fully subsidised - Special Authority removed
r Asthma or COPD New Zealand March 2016
– Inhaled Corticosteroids
IDE
halation
00mcg/dose
ose
FLUTICASONE propionate
Aerosol inhalers
50mcg/dose 125mcg/dose 250mcg/dose
FLUTICASONE propionate
powder for inhalation
50mcg/dose 125mcg/dose
250mcg/dose
buhaler Floair Flixotide Flixotide Accuhaler
proximately
as standard
ipropionate
ne)
Fluticasone and beclomethasone dipropionate are NOT dose equivalent
Fluticasone is approximately twice as potent as standard beclomethasone dipropionate
(Beclazone)
CS & LABA
Combination ONCE
daily ICS & LABA
SONE PROPIONATE & SALMETEROL
Aerosol inhaler
0mcg fluticasone propionate &
25mcg salmeterol/puff
5mcg fluticasone propionate &
25mcg salmeterol/puff
subsidised: 250mcg fluticasone
pionate & 25mcg salmeterol/puff
FLUTICASONE PROPIONATE &
SALMETEROL
powder for inhalation
100mcg fluticasone propionate &
50mcg salmeterol/dose
250mcg fluticasone propionate &
50mcg salmeterol/dose
FLUTICASONE FUROATE &
VILANTEROL
powder for inhalation
Fluticasone furoate 100mcg &
vilanterol 25 mcg
(Asthma and COPD)
Fluticasone furoate 200mcg &
vilanterol 25 mcg
(Asthma only)
Fully subsidised - Special Authority removed
ma or COPD New Zealand March 2016
ed Corticosteroids
dose
FLUTICASONE propionate
Aerosol inhalers
50mcg/dose 125mcg/dose 250mcg/dose
FLUTICASONE propionate
powder for inhalation
50mcg/dose 125mcg/dose
250mcg/dose
Floair Flixotide Flixotide Accuhaler
ely
ard
ate
Fluticasone and beclomethasone dipropionate are NOT dose equivalent
Fluticasone is approximately twice as potent as standard beclomethasone dipropionate
(Beclazone)
ABA
Combination ONCE
daily ICS & LABA
ROPIONATE & SALMETEROL
erosol inhaler
icasone propionate &
g salmeterol/puff
ticasone propionate &
g salmeterol/puff
sed: 250mcg fluticasone
& 25mcg salmeterol/puff
FLUTICASONE PROPIONATE &
SALMETEROL
powder for inhalation
100mcg fluticasone propionate &
50mcg salmeterol/dose
250mcg fluticasone propionate &
50mcg salmeterol/dose
FLUTICASONE FUROATE &
VILANTEROL
powder for inhalation
Fluticasone furoate 100mcg &
vilanterol 25 mcg
(Asthma and COPD)
Fluticasone furoate 200mcg &
vilanterol 25 mcg
(Asthma only)
Fully subsidised - Special Authority removed
BUDESONIDE
powder for inhalation
0mcg/dose 200mcg/dose
400mcg/dose
FLUTICASONE propionate
Aerosol inhalers
50mcg/dose 125mcg/dose 250mcg/dose
FLUTICASONE propionate
powder for inhalation
50mcg/dose 125mcg/dose
250mcg/dose
Pulmicort Turbuhaler Floair Flixotide Flixotide Accuhaler
udesonide is approximately
e same potency as standard
eclomethasone dipropionate
(Beclazone)
Fluticasone and beclomethasone dipropionate are NOT dose equivalent
Fluticasone is approximately twice as potent as standard beclomethasone dipropionate
(Beclazone)
mbination ICS & LABA
Combination ONCE
daily ICS & LABA
FLUTICASONE PROPIONATE & SALMETEROL
Aerosol inhaler
50mcg fluticasone propionate &
25mcg salmeterol/puff
125mcg fluticasone propionate &
25mcg salmeterol/puff
Not subsidised: 250mcg fluticasone
propionate & 25mcg salmeterol/puff
FLUTICASONE PROPIONATE &
SALMETEROL
powder for inhalation
100mcg fluticasone propionate &
50mcg salmeterol/dose
250mcg fluticasone propionate &
50mcg salmeterol/dose
FLUTICASONE FUROATE &
VILANTEROL
powder for inhalation
Fluticasone furoate 100mcg &
vilanterol 25 mcg
(Asthma and COPD)
Fluticasone furoate 200mcg &
vilanterol 25 mcg
(Asthma only)
400
terol
se
RexAir Seretide Seretide Accuhaler Breo Ellipta
cg
dose
dose
Inhaler presentations are NOT dose equivalent with Accuhaler
Inhalers contain 25mcg salmeterol - Accuhalers contain 50mcg salmeterol
Inhaler: TWO puffs twice daily; Accuhaler: ONE inhalation twice daily
Fluticasone furoate
100mcg ONCE daily
is approx. equivalent to
Fully subsidised - Special Authority removed
nhalers for Asthma or COPD New Zealand March 2016
ICS – Inhaled Corticosteroids
BUDESONIDE
owder for inhalation
g/dose 200mcg/dose
400mcg/dose
FLUTICASONE propionate
Aerosol inhalers
50mcg/dose 125mcg/dose 250mcg/dose
FLUTICASONE propionate
powder for inhalation
50mcg/dose 125mcg/dose
250mcg/dose
ulmicort Turbuhaler Floair Flixotide Flixotide Accuhaler
sonide is approximately
me potency as standard
methasone dipropionate
(Beclazone)
Fluticasone and beclomethasone dipropionate are NOT dose equivalent
Fluticasone is approximately twice as potent as standard beclomethasone dipropionate
(Beclazone)
nation ICS & LABA
Combination ONCE
daily ICS & LABA
FLUTICASONE PROPIONATE & SALMETEROL
Aerosol inhaler
50mcg fluticasone propionate &
25mcg salmeterol/puff
125mcg fluticasone propionate &
25mcg salmeterol/puff
Not subsidised: 250mcg fluticasone
propionate & 25mcg salmeterol/puff
FLUTICASONE PROPIONATE &
SALMETEROL
powder for inhalation
100mcg fluticasone propionate &
50mcg salmeterol/dose
250mcg fluticasone propionate &
50mcg salmeterol/dose
FLUTICASONE FUROATE &
VILANTEROL
powder for inhalation
Fluticasone furoate 100mcg &
vilanterol 25 mcg
(Asthma and COPD)
Fluticasone furoate 200mcg &
vilanterol 25 mcg
(Asthma only)
l
RexAir Seretide Seretide Accuhaler Breo Ellipta
e
Inhaler presentations are NOT dose equivalent with Accuhaler
Inhalers contain 25mcg salmeterol - Accuhalers contain 50mcg salmeterol
Inhaler: TWO puffs twice daily; Accuhaler: ONE inhalation twice daily
If extra inhaled corticosteroid is needed, change to the higher strength presentation
or add separate inhaled corticosteroid
Fluticasone furoate
100mcg ONCE daily
is approx. equivalent to
fluticasone propionate
250mcg TWICE daily
Fully subsidised - Special Authority removed
BUDESONIDE
owder for inhalation
g/dose 200mcg/dose
400mcg/dose
FLUTICASONE propionate
Aerosol inhalers
50mcg/dose 125mcg/dose 250mcg/dose
FLUTICASONE propionate
powder for inhalation
50mcg/dose 125mcg/dose
250mcg/dose
ulmicort Turbuhaler Floair Flixotide Flixotide Accuhaler
sonide is approximately
me potency as standard
methasone dipropionate
(Beclazone)
Fluticasone and beclomethasone dipropionate are NOT dose equivalent
Fluticasone is approximately twice as potent as standard beclomethasone dipropionate
(Beclazone)
nation ICS & LABA
Combination ONCE
daily ICS & LABA
FLUTICASONE PROPIONATE & SALMETEROL
Aerosol inhaler
50mcg fluticasone propionate &
25mcg salmeterol/puff
125mcg fluticasone propionate &
25mcg salmeterol/puff
Not subsidised: 250mcg fluticasone
propionate & 25mcg salmeterol/puff
FLUTICASONE PROPIONATE &
SALMETEROL
powder for inhalation
100mcg fluticasone propionate &
50mcg salmeterol/dose
250mcg fluticasone propionate &
50mcg salmeterol/dose
FLUTICASONE FUROATE &
VILANTEROL
powder for inhalation
Fluticasone furoate 100mcg &
vilanterol 25 mcg
(Asthma and COPD)
Fluticasone furoate 200mcg &
vilanterol 25 mcg
(Asthma only)
l
RexAir Seretide Seretide Accuhaler Breo Ellipta
e
Inhaler presentations are NOT dose equivalent with Accuhaler
Inhalers contain 25mcg salmeterol - Accuhalers contain 50mcg salmeterol
Inhaler: TWO puffs twice daily; Accuhaler: ONE inhalation twice daily
Fluticasone furoate
100mcg ONCE daily
is approx. equivalent to
Fully subsidised - Special Authority removed

2. ©Respiratory Quality Improvement Group, June 2016
Inhaler Devices Identification Chart
Long Acting Beta2 Agonists (LABA)
SYMPTOM
CONTROLLERS
SALMETEROL Aerosol inhaler and Accuhaler FORMOTEROL (eformoterol) INDACATEROL
25mcg 25mcg 50mcg 6mcg 12mcg 150mcg 300mcg
Meterol Serevent Serevent Accuhaler Oxis Turbuhaler Foradil Aerolizer device Onbrez Breezhaler
Long Acting Muscarinic Antagonists (LAMA)
Combination Long Acting Muscarinc Antagonists (LAMA)
+ Long Acting Beta2 Agonists (LABA)
TIOTROPIUM UMECLIDINIUM GLYCOPYRRONIUM
TIOTROPIUM +
OLODATEROL
UMECLIDINIUM +
VILANTEROL
GLYCOPYRRONIUM +
INDACATEROL
18mcg 2.5mcg 62.5mcg 50mcg 2.5/2.5 62.5/25 50/110
Spiriva Handihaler Spiriva Respimat Incruse Ellipta Seebri Breezhaler Spiolto Anoro Ellipta Ultibro Breezhaler
NOTES
• Beclazone and Qvar are NOT dose equivalent
• Fluticasone furoate 100mcg DAILY is approximately equivalent to fluticasone propionate 250mcg BD
• Breo Ellipta 200/25 is not subsidised
• Symbicort 400/12 and Seretide Accuhaler 100/50 and 250/50 can not be prescribed as greater than 2 doses per day
• The therapeutic dose of tiotropium when delivered via Respimat device (Spiriva Respimat or Spiolto) is 5microgram daily ie. two doses inhaled once daily
• Tiotropium (handihaler and respimat) – require Special Authority SA1568 (Actual FEV1 as a % of predicted <60%)
• Glycopyrronium – Subsidy by endorsement “certified condition” or “COPD confirmed by spirometry” (post bronchodilator FEV1/FVC < LLN or <0.7)
• Umeclidinium – Subsidy by endorsement “certified condition” or “COPD confirmed by spirometry” (post bronchodilator FEV1/FVC < LLN or <0.7)
• Prescribing Combination LAMA + LABA - all combinations (Spiolto, Anoro Ellipta, Ultibro) require Special Authority SA1584 (same form for all combinations)
*Inhalers not depicted include Mast Cell Stabilisers including: SODIUM CROMOGLYCATE powder for inhalation (Intal Spincaps and spinhaler 20mg/dose) and aerosol inhaler (Intal Forte 5mg/puff) and
NEDOCROMIL aerosol inhaler (Tilade 2mg/puff)
SALMETEROL
Aerosol inhaler
25mcg/dose
SALMETEROL
Powder for inhalation
50mcg/dose
FORMOTEROL (eformoterol)
6mcg/dose powder for
inhalation
FORMOTEROL
12mcg/dose powd
Meterol Serevent Serevent Accuhaler Oxis Turbuhaler
Foradil capsule con
inhalation via A
Inhaler presentations are NOT dose equivalent with Accuhaler
Inhaler - 25mcg salmeterol/puff; Accuhaler - 50mcg salmeterol/dose
Aerosol inhaler TWO puffs twice daily Accuhaler ONE inhalation twice daily
Oxis and Foradil are NOT dose equiva
Oxis contains 6mcg/dose
Foradil contains 12mcg/capsule for inha
TIOTROPIUM
Powder for inhalation 18mcg/dose
TIOTROPIUM
solution for inhalation 2.5mcg/inhalation
UMECLIDINIUM
powder for inhalation 62.5mcg/dose
Spiriva capsule containing powder for
inhalation via Handihaler device
Adult dose: 18mcg inhaled ONCE daily
Spiriva Respimat
Adult dose: 2 puffs (5mcg) ONCE daily
Incruse Ellipta
Indication – COPD: ONE dose inhaled ONCE
Combination LAMA & ‘ultra’ long-acting beta2 agonist (LA
For asthma, MUST be used in combination with an inhaled corticosteroid refer http://www.nzf.org.nz/nzf_170
Special Authority required for Tiotropium see Note 1 No Special Au
script must be end
LAMA – Long Acting Muscarinic
Antagonists (see note 3)
(see note 3)
SALMETEROL
Aerosol inhaler
25mcg/dose
SALMETEROL
Powder for inhalation
50mcg/dose
FORMOTEROL (eformoterol)
6mcg/dose powder for
inhalation
FORMOTEROL (efor
12mcg/dose powder fo
Meterol Serevent Serevent Accuhaler Oxis Turbuhaler
Foradil capsule containin
inhalation via Aeroliz
Inhaler presentations are NOT dose equivalent with Accuhaler
Inhaler - 25mcg salmeterol/puff; Accuhaler - 50mcg salmeterol/dose
rosol inhaler TWO puffs twice daily Accuhaler ONE inhalation twice daily
Oxis and Foradil are NOT dose equivalent
Oxis contains 6mcg/dose
Foradil contains 12mcg/capsule for inhalation
TIOTROPIUM
Powder for inhalation 18mcg/dose
TIOTROPIUM
solution for inhalation 2.5mcg/inhalation
UMECLIDINIUM
powder for inhalation 62.5mcg/dose
iriva capsule containing powder for
inhalation via Handihaler device
ult dose: 18mcg inhaled ONCE daily
Spiriva Respimat
Adult dose: 2 puffs (5mcg) ONCE daily
Incruse Ellipta
Indication – COPD: ONE dose inhaled ONCE daily
Combination LAMA & ‘ultra’ long-acting beta2 agonist (LABA)
For asthma, MUST be used in combination with an inhaled corticosteroid refer http://www.nzf.org.nz/nzf_1706
pecial Authority required for Tiotropium see Note 1 No Special Authorit
script must be endorsed
LAMA – Long Acting Muscarinic
Antagonists (see note 3)
(see note 3)
SALMETEROL
Aerosol inhaler
25mcg/dose
SALMETEROL
Powder for inhalation
50mcg/dose
FORMOTEROL (eformoterol)
6mcg/dose powder for
inhalation
FORMOTEROL (eformoterol)
12mcg/dose powder for inhalatio
ol Serevent Serevent Accuhaler Oxis Turbuhaler
Foradil capsule containing powder
inhalation via Aerolizer device
r presentations are NOT dose equivalent with Accuhaler
25mcg salmeterol/puff; Accuhaler - 50mcg salmeterol/dose
er TWO puffs twice daily Accuhaler ONE inhalation twice daily
Oxis and Foradil are NOT dose equivalent
Oxis contains 6mcg/dose
Foradil contains 12mcg/capsule for inhalation
TIOTROPIUM
inhalation 18mcg/dose
TIOTROPIUM
solution for inhalation 2.5mcg/inhalation
UMECLIDINIUM
powder for inhalation 62.5mcg/dose
ule containing powder for
via Handihaler device
18mcg inhaled ONCE daily
Spiriva Respimat
Adult dose: 2 puffs (5mcg) ONCE daily
Incruse Ellipta
Indication – COPD: ONE dose inhaled ONCE daily
Seeb
Ind
Combination LAMA & ‘ultra’ long-acting beta2 agonist (LABA)
For asthma, MUST be used in combination with an inhaled corticosteroid refer http://www.nzf.org.nz/nzf_1706
Spec
hority required for Tiotropium see Note 1 No Special Authority required
script must be endorsed that patie
LAMA – Long Acting Muscarinic
Antagonists (see note 3)
(see note 3)
LABA – Long Acting Beta2 Agonists ‘Ultra’ long-acting bet
agonist (see note 3)
SALMETEROL
Powder for inhalation
50mcg/dose
FORMOTEROL (eformoterol)
6mcg/dose powder for
inhalation
FORMOTEROL (eformoterol)
12mcg/dose powder for inhalation
INDACATEROL
powder for inhalation
150 mcg/dose or 300 mcg/d
ent Serevent Accuhaler Oxis Turbuhaler
Foradil capsule containing powder for
inhalation via Aerolizer device
Onbrez capsules containing po
for inhalation via Breezhaler d
T dose equivalent with Accuhaler
; Accuhaler - 50mcg salmeterol/dose
ly Accuhaler ONE inhalation twice daily
Oxis and Foradil are NOT dose equivalent
Oxis contains 6mcg/dose
Foradil contains 12mcg/capsule for inhalation
Indication - COPD
150mcg OR 300mcg
inhaled via Breezhaler ONCE d
e
TIOTROPIUM
solution for inhalation 2.5mcg/inhalation
UMECLIDINIUM
powder for inhalation 62.5mcg/dose
GLYCOPYRRONIUM
powder for inhalation 50mcg/dose
or
ily
Spiriva Respimat
Adult dose: 2 puffs (5mcg) ONCE daily
Incruse Ellipta
Indication – COPD: ONE dose inhaled ONCE daily
Seebri capsules containing powder for inhala
via Breezhaler device
Indication – COPD: 50mcg inhaled ONCE da
Combination LAMA & ‘ultra’ long-acting beta2 agonist (LABA)
TH OLODATEROL
lation
UMECLIDINIUM WITH VILANTEROL
powder for inhalation
GLYCOPYRRONIUM WITH INDACATEROL
powder for inhalation
ST be used in combination with an inhaled corticosteroid refer http://www.nzf.org.nz/nzf_1706
Special Authority required see Note 2
ropium see Note 1 No Special Authority required for umeclidinium or glycopyrronium –
script must be endorsed that patient has had COPD confirmed by spirom
LAMA – Long Acting Muscarinic
Antagonists (see note 3)
(see note 3)
(see note 3)
aler Oxis Turbuhaler
Foradil capsule containing powder for
inhalation via Aerolizer device
Onbrez capsules containing powder
for inhalation via Breezhaler device
r
dose
ce daily
Oxis and Foradil are NOT dose equivalent
Oxis contains 6mcg/dose
Foradil contains 12mcg/capsule for inhalation
Indication - COPD
150mcg OR 300mcg
inhaled via Breezhaler ONCE daily
M
mcg/inhalation
UMECLIDINIUM
powder for inhalation 62.5mcg/dose
GLYCOPYRRONIUM
powder for inhalation 50mcg/dose
at
g) ONCE daily
Incruse Ellipta
Indication – COPD: ONE dose inhaled ONCE daily
Seebri capsules containing powder for inhalation
via Breezhaler device
Indication – COPD: 50mcg inhaled ONCE daily
on LAMA & ‘ultra’ long-acting beta2 agonist (LABA)
UMECLIDINIUM WITH VILANTEROL
powder for inhalation
Umeclidinium 62.5 mcg with vilanterol 25 mcg
GLYCOPYRRONIUM WITH INDACATEROL
powder for inhalation
glycopyrronium 50 mcg with indacaterol 110 mcg
Special Authority required see Note 2
No Special Authority required for umeclidinium or glycopyrronium –
script must be endorsed that patient has had COPD confirmed by spirometry
MA – Long Acting Muscarinic
Antagonists (see note 3)
repared by Helen Cant Clinical Pharmacist Tokoroa March 2016. Disclaimer: This information is obtained from current relevant sources; individual clinical cir
apsule containing powder for
tion via Handihaler device
se: 18mcg inhaled ONCE daily
Spiriva Respimat
Adult dose: 2 puffs (5mcg) ONCE daily
Incruse Ellipta
Indication – COPD: ONE dose inhaled ONCE
Combination LAMA & ‘ultra’ long-acting beta2 agonist (LA
IOTROPIUM BROMIDE WITH OLODATEROL
solution for inhalation
Tiotropium 2.5mcg with olodaterol 2.5mcg
UMECLIDINIUM WITH VILANTEROL
powder for inhalation
Umeclidinium 62.5 mcg with vilanterol 25 mcg
Spiolto Respimat
ndication COPD: TWO inhalations ONCE daily
Anoro Ellipta
Indication COPD: ONE inhalation ONCE daily
(see note 3)
ch 2016. Disclaimer: This information is obtained from current relevant sources; individual clinical circumstances should be considered when making treatment deci
powder for inhalation 62.5mcg/dose
Spiriva Respimat
se: 2 puffs (5mcg) ONCE daily
Incruse Ellipta
Indication – COPD: ONE dose inhaled ONCE daily
Seebri capsules containing powder for
via Breezhaler device
Indication – COPD: 50mcg inhaled ON
Combination LAMA & ‘ultra’ long-acting beta2 agonist (LABA)
L UMECLIDINIUM WITH VILANTEROL
powder for inhalation
Umeclidinium 62.5 mcg with vilanterol 25 mcg
GLYCOPYRRONIUM WITH INDACATEROL
powder for inhalation
glycopyrronium 50 mcg with indacaterol 110
y
Anoro Ellipta
Indication COPD: ONE inhalation ONCE daily
Ultibro capsule containing powder for inhala
via Breezhaler device
Indication COPD: ONE inhalation ONCE dai
Special Authority required see Note 2